A new molecular diagnostic test for Bundibugyo Ebola virus has been approved by the WHO, offering faster and more reliable confirmation of infections in Congo and Uganda amidst a growing outbreak. This development is crucial as existing treatments for the Zaire strain are not effective against Bundibugyo. The Democratic Republic of Congo faces significant challenges with over 1,400 cases, while Uganda shows signs of containment.
